高级检索
当前位置: 首页 > 详情页

Internet of things-based management versus standard management of home noninvasive ventilation in COPD patients with hypercapnic chronic respiratory failure: a multicentre randomized controlled non-inferiority trial

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Pulmonary Medicine and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China [2]Department of Pulmonary Medicine, Tong Ren Hospital, Jiaotong University, Shanghai, China [3]Department of Pulmonary Medicine, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China [4]Department of Pulmonary Medicine, Pudong New Area People’s Hospital, Shanghai, China [5]Department of Pulmonary Medicine, Minhang Branch of Zhongshan Hospital, Fudan University, Shanghai, China [6]Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, China [7]Department of Pulmonary Medicine, Jiading District Central Hospital Affiliated Shanghai University of Medicine &Health Sciences, Shanghai, China [8]Department of Pulmonary Medicine, Zhongshan Xuhui Hospital, Fudan University, Shanghai, China [9]Department of Pulmonary Medicine, Traditional Chinese Medicine Hospital of Kunshan, Jiangsu, China [10]Department of Pulmonary Medicine, Pudong Hospital, Shanghai, China [11]Department of Pulmonary Medicine, Putuo District Liqun Hospital, Shanghai, China [12]Department of Pulmonary Medicine, Shanghai Ninth People’s Hospital, Jiaotong University, Shanghai, China [13]Shanghai Respiratory Research Institute, Fudan University, Shanghai, China [14]Shanghai Institute of Infectious Disease and Biosecurity, Shanghai, China [15]Shanghai Key Laboratory of Lung Inflammation and Injury, Zhongshan Hospital, Fudan University, Shanghai, China
出处:
ISSN:

关键词: Chronic obstructive pulmonary disease Noninvasive positive pressure ventilation Hypercapnia respiratory failure Internet of things Telemedicine

摘要:
Effective monitoring and management are crucial during long-term home noninvasive positive pressure ventilation (NPPV) in patients with hypercapnic chronic obstructive pulmonary disease (COPD). This study investigated the benefit of Internet of Things (IOT)-based management of home NPPV.This multicenter, prospective, parallel-group, randomized controlled non-inferiority trial enrolled patients requiring long-term home NPPV for hypercapnic COPD. Patients were randomly assigned (1:1), via a computer-generated randomization sequence, to standard home management or IOT management based on telemonitoring of clinical and ventilator parameters over 12 months. The intervention was unblinded, but outcome assessment was blinded to management assignment. The primary outcome was the between-group comparison of the change in health-related quality of life, based on severe respiratory insufficiency questionnaire scores with a non-inferiority margin of -5. This study is registered with Chinese Clinical Trials Registry (No. ChiCTR1800019536).Overall, 148 patients (age: 72.7 ± 6.8 years; male: 85.8%; forced expiratory volume in 1 s: 0.7 ± 0.3 L; PaCO2: 66.4 ± 12.0 mmHg), recruited from 11 Chinese hospitals between January 24, 2019, and June 28, 2021, were randomly allocated to the intervention group (n = 73) or the control group (n = 75). At 12 months, the mean severe respiratory insufficiency questionnaire score was 56.5 in the intervention group and 50.0 in the control group (adjusted between-group difference: 6.26 [95% CI, 3.71-8.80]; P < 0.001), satisfying the hypothesis of non-inferiority. The 12-month risk of readmission was 34.3% in intervention group compared with 56.0% in the control group, adjusted hazard ratio of 0.56 (95% CI, 0.34-0.92; P = 0.023). No severe adverse events were reported.Among stable patients with hypercapnic COPD, using IOT-based management for home NPPV improved health-related quality of life and prolonged the time to readmission.Air Liquide Healthcare (Beijing) Co., Ltd.© 2024 The Authors.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 医学:内科
JCR分区:
出版当年[2022]版:
Q1 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q1 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Department of Pulmonary Medicine and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Pulmonary Medicine and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China [13]Shanghai Respiratory Research Institute, Fudan University, Shanghai, China [14]Shanghai Institute of Infectious Disease and Biosecurity, Shanghai, China [15]Shanghai Key Laboratory of Lung Inflammation and Injury, Zhongshan Hospital, Fudan University, Shanghai, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)